Loxapine in neurotic anxiety: some modifiers of treatment response.
The authors describe a double-blind trial of six weeks duration which was designed to compare the anxiolytic properties of chlordiazepoxide, loxapine and placebo in a total of 135 anxious neurotic out-patients.
D001007:Anxiety / Q000188:drug therapy; D001008:Anxiety Disorders / Q000188:drug therapy*; D002707:Chlordiazepoxide / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003863:Depression / Q000188:drug therapy; D003989:Dibenzoxazepines / Q000627:therapeutic use*; D004311:Double-Blind Method; D004341:Drug Evaluation; D006801:Humans; D008152:Loxapine / Q000627:therapeutic use*; D010919:Placebos
D003989:Dibenzoxazepines; D010919:Placebos; D002707:Chlordiazepoxide; D008152:Loxapine